Clinical Trials Browser

Withdrawn × Lung Neoplasms × Trastuzumab × Clear all

NCT01679743 2019-11-15

GRN1005 for Brain Metastases From Breast or Lung Cancer

Phase 2 Withdrawn

Breast Neoplasms, Lung Neoplasms